← Back to Search

Spanish-Language Hearing Loss Toolkit for Hearing Loss

N/A
Recruiting
Led By Michelle Arnold, Au.D., Ph.D.
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants will include community-dwelling, Spanish-speaking (monolingual or bilingual) adults over age 50 who self-identify as Hispanic/Latino
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed 4-6 weeks post baseline assessment
Awards & highlights

Study Summary

This trial is testing whether Spanish-language hearing education materials help adults better understand their hearing loss and how to manage it.

Who is the study for?
This trial is for Spanish-speaking adults over 50 who identify as Hispanic/Latino, have significant hearing loss or difficulty hearing. To join, they must experience more than a mild level of hearing loss across various pitches or report substantial hearing challenges.Check my eligibility
What is being tested?
The study is testing educational materials in Spanish designed to help participants understand and manage their hearing loss better. It compares the effectiveness of a new toolkit against existing ASHA audiology handouts.See study design
What are the potential side effects?
Since this trial involves educational materials rather than medical treatments, there are no direct physical side effects expected from participating in this study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 50, Hispanic/Latino, and speak Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed 4-6 weeks post baseline assessment
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed 4-6 weeks post baseline assessment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self-Efficacy for Chronic Health Condition Management (generic )
Hearing impairment
Secondary outcome measures
Hearing Loss Knowledge, Attitudes, and Behaviors

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental GroupExperimental Treatment1 Intervention
This group will receive the Spanish-Language Hearing Loss Toolkit materials.
Group II: Active Control GroupActive Control1 Intervention
This group will receive standard of care Spanish language information from the American Speech-Language-Hearing Association (ASHA) Audiology Series

Find a Location

Who is running the clinical trial?

University of South FloridaLead Sponsor
404 Previous Clinical Trials
185,129 Total Patients Enrolled
7 Trials studying Hearing Loss
1,492 Patients Enrolled for Hearing Loss
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
327 Previous Clinical Trials
178,206 Total Patients Enrolled
54 Trials studying Hearing Loss
19,840 Patients Enrolled for Hearing Loss
Michelle Arnold, Au.D., Ph.D.Principal InvestigatorUniversity of South Florida

Media Library

Spanish-Language Hearing Loss Toolkit for Self-Management Clinical Trial Eligibility Overview. Trial Name: NCT04534387 — N/A
Hearing Loss Research Study Groups: Experimental Group, Active Control Group
Hearing Loss Clinical Trial 2023: Spanish-Language Hearing Loss Toolkit for Self-Management Highlights & Side Effects. Trial Name: NCT04534387 — N/A
Spanish-Language Hearing Loss Toolkit for Self-Management 2023 Treatment Timeline for Medical Study. Trial Name: NCT04534387 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots for enrolment in this medical experiment?

"That is correct. According to clinicaltrials.gov, this study launched on April 22nd 2021 and is still actively recruiting 110 participants from one location as of the last update made in April 6th 2022."

Answered by AI

What is the upper boundary of participants that can join this experiment?

"Affirmative. According to clinicaltrials.gov, this medical trial is actively recruiting patients and was posted on April 22nd 2021. Most recently updated on April 6th 2022, the study hopes to enrol 110 participants from a single location."

Answered by AI
~0 spots leftby Mar 2024